Publikation
Generative AI
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Publikation | October 2015
Canada’s Patented Medicines Notice of Compliance Regulations (PM(NOC) Regulations) are loosely based on the U.S. Hatch-Waxman regime and are meant to link patent protection with the drug approval process. As required by the PM(NOC) Regulations, Health Canada maintains a Patent Register (similar to the U.S. Orange Book).
Read more (pdf 1,006kb)
Publikation
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Publikation
Last November the Financial Conduct Authority (FCA) published Policy Statement 23/16 (PS23/16) containing final rules and guidance on sustainability disclosure requirements (SDR) and investment labels (UK SDR regime).
Publikation
We are delighted to announce that Al Hounsell, Director of Strategic Innovation & Legal Design based in our Toronto office, has been named 'Innovative Leader of the Year' at the International Legal Technology Association (ILTA) Awards.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023